Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R2-MTX in Newly Diagnosed PCNSL
NCT04934579Phase 2Completed
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jan 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in primary central nervous system lymphoma (PCNSL), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Jan 2020; status: completed.
02
Drugs
lenalidomide
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT04934579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04934579.